Related Experiment Videos
Cost analysis of two implantable narcotic delivery systems
Journal of Pain and Symptom Management
|August 1, 1991
Summary
For long-term pain management, implanted narcotic delivery systems (Type-II) are more cost-effective than exteriorized epidural catheter systems (Type-I) after three months. This analysis focuses on the financial benefits of Type-II systems.
Area of Science:
- Pain Management
- Medical Device Technology
- Health Economics
Background:
- Implantable narcotic delivery systems are crucial for chronic pain management.
- Two primary systems exist: Type-I (exteriorized epidural catheter) and Type-II (implanted pump).
- Comparative cost-effectiveness is essential for clinical and economic decision-making.
Purpose of the Study:
- To compare the costs of Type-I and Type-II implantable narcotic delivery systems.
- To determine the cost-effectiveness of each system for long-term pain management.
- To provide data for informed choices in pain management therapy.
Main Methods:
- Cost analysis of two implantable narcotic delivery systems.
- Review of patient hospital financial records.
- Analysis of Homecare vendor quotations.
Main Results:
- Type-II implanted systems demonstrate cost savings for treatment durations exceeding three months.
- Type-I systems with external pumps incur higher long-term costs compared to Type-II.
- Cost-effectiveness favors Type-II for extended patient care.
Conclusions:
- Implanted narcotic delivery systems (Type-II) offer significant financial advantages for long-term pain management.
- Healthcare providers should consider Type-II systems for patients needing >3 months of therapy.
- Economic factors strongly support the adoption of implanted systems for chronic pain.